Skip to main content
. 2021 Nov 6;61(11):1693–1698. doi: 10.2169/internalmedicine.8460-21

Table 2.

Univariate and Multivariate Analyses for Factors Associated with MG-ADL Score.

Variables Univariate Multivariate
MG-ADL [median (IQR)] p value Regression coefficient (95%CI) p value
(Intercept) 1.77 (-0.43, 3.97) 0.114
Never-smoker 4 (2-6)
Ex-smoker 4 (2-6) 0.21 (-0.69, 1.12) 0.641
Current-smoker 4 (3-5) 0.825† 0.22 (-1.01, 1.46) 0.720
Male 3 (2-6)
Female 4 (3-6) 0.024 0.71 (-0.20, 1.61) 0.124
Age at survey -0.048‡ 0.515 0.01 (-0.02, 0.03) 0.697
Disease duration (years) -0.0597‡ 0.421 0.02 (-0.02, 0.06) 0.322
Anti-AChR antibody-negative 5 (3-7)
Anti-AChR antibody-positive 4 (2-6) 0.036 -1.12 (-2.09, -0.15) 0.024
Ocular 3 (1-4)
Generalized 4 (2-6) 0.010 0.77 (-0.23, 1.77) 0.129
Non-thymoma 4 (2-6)
Thymoma 4 (2-5) 0.730 -0.26 (-1.14, 0.62) 0.559
Without steroid or immunosuppressant 2 (1-4)
With steroid or immunosuppressant 4 (3-6) <0.001 2.13 (0.94, 3.31) 0.001

MG: myasthenia gravis, ADL: activities of daily living, IQR: interquartile range, CI: confidence interval, AChR: acetylcholine receptor, p value by Kruskal-Wallis test, Spearman’s rank correlation coefficient